Cancer and Leukemia Group B Presents Results At American Society of Clinical Oncology From Randomized Study Of Cetuximab And Chemotherapy In First-Line Metastatic Colorectal Cancer

ATLANTA--(BUSINESS WIRE)--June 5, 2006--The Cancer and Leukemia Group B today announced findings from a clinical trial of cetuximab and chemotherapy in previously untreated patients with metastatic colorectal cancer. This study was presented today in an oral session at the American Society of Clinical Oncology (ASCO) 42nd Annual Meeting by Alan Venook, M.D., Professor of Medicine, University of California, San Francisco on behalf of the CALGB.